On ECHEMI
Home > Drugs > Artificial Bezoar Metronidazole Capsules

Artificial Bezoar Metronidazole Capsules

Ingredients

This product is a compound preparation, each tablet contains 0.2g of metronidazole and 5mg of artificial bezoar.

Name Description Content CAS NO. Manufacturer
MetronidazoleIngredients

443-48-1 39
Atificial Cow-bezoarIngredients

1002-00-2 2

Appearance

This product is a capsule, and the contents are yellow or slightly yellow granules or powder.

Usage and Dosage

Oral administration: 2 capsules at a time, 3 times a day.

Adverse Reactions

1. The most serious adverse reactions of this product are epileptic seizures and peripheral neuropathy at high doses, the latter of which is mainly manifested by numbness and paresthesia of the extremities. In some cases, long-term use of the drug may cause persistent peripheral neuropathy. 2. Other common adverse reactions include: (1) Gastrointestinal reactions, such as nausea, loss of appetite, vomiting, diarrhea, abdominal discomfort, taste changes, dry mouth, metallic taste in the mouth, etc. (2) Reversible neutropenia. (3) Allergic reactions, such as rash, urticaria, itching, etc. (4) Central nervous system symptoms, such as headache, dizziness, syncope, paresthesia, numbness of the extremities, ataxia and mental confusion, etc. (5) Other symptoms include fever, vaginal candidiasis, cystitis, dysuria, dark urine color, etc., which are all reversible and will recover on their own after stopping the drug.

Precautions

1. Patients allergic to metronidazole or azole drugs are prohibited from using this product. 2. Patients with active central nervous system diseases and blood diseases are prohibited from using this product. 3. Pregnant women are prohibited from using this product. 4. People who drink alcohol are prohibited from using this product.

Special Population Medication

Precautions for children: Children should use it with caution and in reduced doses. Precautions for pregnancy and lactation: Metronidazole can cross the placenta and quickly enter the fetal circulation. Animal experiments have found that oral administration is non-toxic to the fetus. There is no sufficient and rigorous control examination of the effects of metronidazole on the fetus, so it is contraindicated for pregnant women. The concentration of metronidazole in breast milk is similar to that in blood. Animal experiments have shown that this product has a carcinogenic effect on young mice, so it is not suitable for lactating women. If the drug must be used, breastfeeding should be interrupted, and breastfeeding can be resumed 24 to 48 hours after the end of the treatment course. Precautions for the elderly: Due to decreased liver function in the elderly, the pharmacodynamics of this product changes when it is used, and the blood concentration needs to be monitored.

Drug Interactions

1. Metronidazole can inhibit the metabolism of warfarin and other oral anticoagulants, enhance their effects, and cause the prothrombin time to be prolonged. 2. When used in combination with drugs that induce liver microsomal enzymes, such as phenytoin sodium and phenobarbital, it can enhance the metabolism of this product, reduce the blood drug concentration, and slow down the excretion of phenytoin sodium.

Storage

Keep away from light and store in a sealed container.

Packaging Specification

10s

Validity Period

36 months

Manufacturer

Chongqing Tianzhi Pharmaceutical Co., Ltd.

  • Founded in:

    2016-10-31
  • Address:

    Building 1, No. 10 Dongpu Avenue, Zhaojia Street, Kaizhou District, Chongqing
  • Tax NO.:

    91500234MA5U87EPX1
  • Registered Funds:

    356.5497 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.